Latest Insider Transactions at Cardiovascular Systems Inc (CSII)
This section provides a real-time view of insider transactions for Cardiovascular Systems Inc (CSII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cardiovascular Systems Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cardiovascular Systems Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2022
|
David Whitescarver VP of Corp. Dev. and IP |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+7.97%
|
-
|
|
Feb 08
2022
|
Stephen J. Rempe Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+9.93%
|
-
|
|
Feb 08
2022
|
Scott R. Ward Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+0.94%
|
-
|
|
Feb 08
2022
|
Rhonda J. Robb Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,477
+3.13%
|
-
|
|
Feb 07
2022
|
Scott R. Ward Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.44%
|
$45,000
$18.52 P/Share
|
|
Feb 07
2022
|
Rhonda J. Robb Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,567
+0.95%
|
$28,206
$18.71 P/Share
|
|
Feb 07
2022
|
Martha Goldberg Aronson Director |
BUY
Open market or private purchase
|
Direct |
2,500
+20.0%
|
$45,000
$18.43 P/Share
|
|
Nov 15
2021
|
Augustine Lawlor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,222
+19.57%
|
-
|
|
Nov 12
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.56%
|
$11,583
$27.2 P/Share
|
|
Nov 12
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.74%
|
$11,583
$27.2 P/Share
|
|
Aug 28
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-0.78%
|
$27,230
$35.38 P/Share
|
|
Aug 28
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,589
-0.97%
|
$55,615
$35.38 P/Share
|
|
Aug 28
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-0.71%
|
$23,835
$35.38 P/Share
|
|
Aug 28
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
486
-0.63%
|
$17,010
$35.38 P/Share
|
|
Aug 28
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,593
-0.8%
|
$160,755
$35.38 P/Share
|
|
Aug 19
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,099
-1.53%
|
$39,564
$36.18 P/Share
|
|
Aug 19
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,107
-1.52%
|
-
|
|
Aug 19
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
925
-1.83%
|
$33,300
$36.18 P/Share
|
|
Aug 19
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
931
-1.81%
|
-
|
|
Aug 19
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,680
-4.49%
|
$168,480
$36.18 P/Share
|
|
Aug 19
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,714
-4.32%
|
-
|
|
Aug 19
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,560
-5.5%
|
$344,160
$36.18 P/Share
|
|
Aug 19
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,630
-5.25%
|
-
|
|
Aug 19
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,095
-4.09%
|
$147,420
$36.18 P/Share
|
|
Aug 19
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,125
-3.96%
|
-
|
|
Aug 19
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,925
-3.67%
|
$105,300
$36.18 P/Share
|
|
Aug 19
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,683
-4.42%
|
-
|
|
Aug 19
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,637
-4.59%
|
$994,932
$36.18 P/Share
|
|
Aug 19
2021
|
Scott R. Ward Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,842
-4.42%
|
-
|
|
Aug 19
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,009
-1.7%
|
$36,324
$36.18 P/Share
|
|
Aug 19
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,015
-1.68%
|
-
|
|
Aug 13
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,568
-2.54%
|
$56,448
$36.07 P/Share
|
|
Aug 13
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,570
-1.65%
|
$380,520
$36.07 P/Share
|
|
Aug 13
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-1.31%
|
$39,888
$36.07 P/Share
|
|
Aug 13
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-1.59%
|
$60,660
$36.07 P/Share
|
|
Aug 13
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,316
-1.78%
|
$119,376
$36.07 P/Share
|
|
Aug 13
2021
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-3.34%
|
$54,936
$36.07 P/Share
|
|
Aug 13
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,102
-1.89%
|
$75,672
$36.07 P/Share
|
|
Aug 13
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,820
-2.44%
|
$65,520
$36.07 P/Share
|
|
Aug 13
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,436
-2.72%
|
$51,696
$36.07 P/Share
|
|
Aug 09
2021
|
Scott R. Ward Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
132,563
+9.61%
|
-
|
|
Aug 09
2021
|
Jeffrey S. Points Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,407
+12.09%
|
-
|
|
Aug 09
2021
|
Rhonda J. Robb Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,588
+10.06%
|
-
|
|
Aug 09
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
22,304
+9.77%
|
-
|
|
Aug 09
2021
|
Sandra Sedo Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,339
+9.54%
|
-
|
|
Aug 09
2021
|
Ryan Egeland Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,751
+11.0%
|
-
|
|
Aug 09
2021
|
John M. Hastings VP Manufacturing & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,308
+13.99%
|
-
|
|
Aug 09
2021
|
David Whitescarver VP of Corp. Dev. and IP |
BUY
Grant, award, or other acquisition
|
Direct |
15,976
+11.87%
|
-
|
|
Aug 09
2021
|
Stephen J. Rempe Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,714
+15.47%
|
-
|
|
Aug 09
2021
|
Augustine Lawlor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,710
+31.03%
|
-
|